News
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Tullow Oil plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: THG plc
Form 8.3 - The Vanguard Group, Inc.: Shaftesbury plc
Innovative Industrial Properties Declares Second Quarter 2022 Dividends
Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the New York Stock Exchange (NYSE: IIPR) focused on the regulated U.S. cannabis industry, announced today
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
DGAP-News: PNE AG: Corporate bond 2022/27 with a volume of euro 55 million successfully placed
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Perion Announces Neutronian’s Study of over 110 Campaigns Demonstrates 2X CTR Lift by Using SORTTM Targeting Technology Over Traditional Third-Party Cookies
Perion Network Ltd. (NASDAQ: PERI) (TASE: PERI) a global advertising technology company that delivers holistic solutions across the three main pillars of digital advertising – ad search, social
DGAP-News: Francotyp-Postalia Holding AG: FP Annual General Meeting with outlook of further transformation with profitable growth
Fix Price Group Ltd. : Notification of PDMR transaction
DGAP-News: Hawesko Holding AG: Annual General Meeting approves payment of a dividend of € 2.50 per share
Travis Perkins: TR1 Notification of Major Share Interest
DGAP-Adhoc: CLIQ Digital raises sales and earnings guidance for 2022
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
DGAP-Adhoc: Allterco JSCo provides American subsidiary Allterco Robotics U.S. with additional financing
'Sparadies' on sixt-neuwagen.de: Attractive special discounts on selected vehicles
Sensorion to Present at the Inner Ear Disorder Therapeutics Summit in June 2022
Regulatory News:
Sensorion (Paris:ALSEN) (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and